Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dai, Hai-ping, Kong, Dan-qing, Shen, Hong-jie, Cui, Wei, Wang, Qian, Li, Zheng, Yin, Jia, Kang, Li-qing, Yu, Lei, Wu, De-pei, Tang, Xiao-wen
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Dai, Hai-ping
Kong, Dan-qing
Shen, Hong-jie
Cui, Wei
Wang, Qian
Li, Zheng
Yin, Jia
Kang, Li-qing
Yu, Lei
Wu, De-pei
Tang, Xiao-wen
description Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.
doi_str_mv 10.6084/m9.figshare.22604309
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_22604309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_22604309</sourcerecordid><originalsourceid>FETCH-LOGICAL-d919-aeb4288fed9edec32753f90644b785b8fb48a196a7d79f16fb5bc2e0066f19ea3</originalsourceid><addsrcrecordid>eNo1kM1ugzAQhLn0UKV9gx72BUgNOAYfUdQ_CalVxR2t8TpYMRiBq4h36kMW1OS0OyPNjPRF0VPC9oIV_LmXe2NPc4cT7dNUMJ4xeR_9llrbYP2ADox1BBl4A8fyO66hJecgdDThuIDxzvkLaVAL4PqeaLAtdNRj8KO3FFY1B-qvqQmHeXQ4BNzKYbHk9BpufT_ihGod8j9hVQSKwoVogK8OnD0TlFUFOGjw2zJ09tTFk53Pm_8Q3Rl0Mz1e7y6qX1_q43tcfb59HMsq1jKRMZLiaVEY0pI0tVmaHzIjmeBc5cVBFUbxAhMpMNe5NIkw6qDalBgTwiSSMNtF_L9WY8DWBmrGyfY4LU3Cmo1l08vmxrK5scz-AEcKc94</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><source>DataCite</source><creator>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</creator><creatorcontrib>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</creatorcontrib><description>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</description><identifier>DOI: 10.6084/m9.figshare.22604309</identifier><language>eng</language><publisher>figshare</publisher><subject>Cancer ; Cell Biology ; FOS: Biological sciences ; FOS: Clinical medicine ; FOS: Health sciences ; Genetics ; Hematology ; Immunology ; Infectious Diseases ; Medicine ; Pharmacology ; Virology</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.22604309$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dai, Hai-ping</creatorcontrib><creatorcontrib>Kong, Dan-qing</creatorcontrib><creatorcontrib>Shen, Hong-jie</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Li, Zheng</creatorcontrib><creatorcontrib>Yin, Jia</creatorcontrib><creatorcontrib>Kang, Li-qing</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Wu, De-pei</creatorcontrib><creatorcontrib>Tang, Xiao-wen</creatorcontrib><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><description>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</description><subject>Cancer</subject><subject>Cell Biology</subject><subject>FOS: Biological sciences</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Genetics</subject><subject>Hematology</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><subject>Pharmacology</subject><subject>Virology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kM1ugzAQhLn0UKV9gx72BUgNOAYfUdQ_CalVxR2t8TpYMRiBq4h36kMW1OS0OyPNjPRF0VPC9oIV_LmXe2NPc4cT7dNUMJ4xeR_9llrbYP2ADox1BBl4A8fyO66hJecgdDThuIDxzvkLaVAL4PqeaLAtdNRj8KO3FFY1B-qvqQmHeXQ4BNzKYbHk9BpufT_ihGod8j9hVQSKwoVogK8OnD0TlFUFOGjw2zJ09tTFk53Pm_8Q3Rl0Mz1e7y6qX1_q43tcfb59HMsq1jKRMZLiaVEY0pI0tVmaHzIjmeBc5cVBFUbxAhMpMNe5NIkw6qDalBgTwiSSMNtF_L9WY8DWBmrGyfY4LU3Cmo1l08vmxrK5scz-AEcKc94</recordid><startdate>20230413</startdate><enddate>20230413</enddate><creator>Dai, Hai-ping</creator><creator>Kong, Dan-qing</creator><creator>Shen, Hong-jie</creator><creator>Cui, Wei</creator><creator>Wang, Qian</creator><creator>Li, Zheng</creator><creator>Yin, Jia</creator><creator>Kang, Li-qing</creator><creator>Yu, Lei</creator><creator>Wu, De-pei</creator><creator>Tang, Xiao-wen</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230413</creationdate><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><author>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d919-aeb4288fed9edec32753f90644b785b8fb48a196a7d79f16fb5bc2e0066f19ea3</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer</topic><topic>Cell Biology</topic><topic>FOS: Biological sciences</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Genetics</topic><topic>Hematology</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><topic>Pharmacology</topic><topic>Virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Dai, Hai-ping</creatorcontrib><creatorcontrib>Kong, Dan-qing</creatorcontrib><creatorcontrib>Shen, Hong-jie</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Li, Zheng</creatorcontrib><creatorcontrib>Yin, Jia</creatorcontrib><creatorcontrib>Kang, Li-qing</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Wu, De-pei</creatorcontrib><creatorcontrib>Tang, Xiao-wen</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dai, Hai-ping</au><au>Kong, Dan-qing</au><au>Shen, Hong-jie</au><au>Cui, Wei</au><au>Wang, Qian</au><au>Li, Zheng</au><au>Yin, Jia</au><au>Kang, Li-qing</au><au>Yu, Lei</au><au>Wu, De-pei</au><au>Tang, Xiao-wen</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><date>2023-04-13</date><risdate>2023</risdate><abstract>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.22604309</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.22604309
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_22604309
source DataCite
subjects Cancer
Cell Biology
FOS: Biological sciences
FOS: Clinical medicine
FOS: Health sciences
Genetics
Hematology
Immunology
Infectious Diseases
Medicine
Pharmacology
Virology
title Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A41%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Dai,%20Hai-ping&rft.date=2023-04-13&rft_id=info:doi/10.6084/m9.figshare.22604309&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_22604309%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true